P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY

• A. Suvannasankha,
• N. Bahlis,
• S. Trudel,
• K. Weisel,
• C. Koenecke,
• A. Oriol,
• P. M. Voorhees,
• A. A. Alonso,
• N. S. Callander,
• M. V. Mateos Manteca,
• N. Reddy,
• S. Hakim,
• N. Patel,
• D. Williams,
• R. C. Jewell,
• X. Zhou,
• I. Gupta,
• A. K. Nooka

Affiliations

A. Suvannasankha

1 Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN, United States of America

N. Bahlis

2 Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB

S. Trudel

3 Princess Margaret Cancer Centre, Toronto, ON, Canada

K. Weisel

4 University Medical Center Hamburg-Eppendorf, Hamburg

C. Koenecke

5 Hannover Medical School, Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany

A. Oriol

6 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

P. M. Voorhees

7 Levine Cancer Institute, Atrium Health, Charlotte, NC, United States of America

A. A. Alonso

8 Hospital Universitario Quirónsalud Madrid, Madrid, Spain

N. S. Callander

9 Carbone Cancer Center, University of Wisconsin, Madison, WI, United States of America

M. V. Mateos Manteca

10 Instituto de Investigación Biomédica de Salamanca and Centro de Investigación del Cáncer, Hospital Universitario de Salamanca, Salamanca, Spain

N. Reddy

11 Merck & Co., Inc., Kenilworth, NJ

S. Hakim

12 GlaxoSmithKline, Upper Providence, PA

N. Patel

13 GlaxoSmithKline, Research Triangle Park, NC

D. Williams

12 GlaxoSmithKline, Upper Providence, PA

R. C. Jewell

13 GlaxoSmithKline, Research Triangle Park, NC

X. Zhou

12 GlaxoSmithKline, Upper Providence, PA

I. Gupta

14 GlaxoSmithKline, Philadelphia, PA

A. K. Nooka

15 Winship Cancer Institute, Emory University Hospital, Atlanta, GA, United States of America